BRD-K06335600-003-16-5
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A011 HELA 24H J01 tizanidine 10.0um.tsv.gz
uterine cervix
Label
Description
A Substance
A 161 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project